StreetInsider.com News Articles

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

SALT LAKE CITY, April 20, 2026 /PRNewswire/ -- bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

Mon, 20 Apr 2026 09:05:00 -0400

Fast diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the United States, modelled analysis shows

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Thu, 09 Apr 2026 09:03:00 -0400

MARCY-L'ÉTOILE, France, April 9, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE^® SPOTFIRE^® for pharmaceutical industries, where this innovative molecular testing system is designed to transform quality control. Building on the proven success of the BIOFIRE^® FILMARRAY^® platform, already adopted by leading global pharmaceutical companies, BIOFIRE^® SPOTFIRE^® introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients.

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Thu, 09 Apr 2026 09:03:00 -0400

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Thu, 09 Apr 2026 09:03:00 -0400